APW
SRPT icon

Aventura Private Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Aventura Private Wealth’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126 Hold
7
– – ﹤0.01% 967
2026
Q1 		$152 Hold
7
– – ﹤0.01% 884
2025
Q4 		$151 Hold
7
– – ﹤0.01% 841
2025
Q3 		$135 Hold
7
– – ﹤0.01% 786
2025
Q2 		$120 Sell
7
-93
-93% -$3.97K ﹤0.01% 764
2025
Q1 		$6.38K Hold
100
– – ﹤0.01% 506
2024
Q4 		$12.2K Buy
+100
New +$12.3K 0.01% 413

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Aventura Private Wealth's SRPT Position: Q2 2026 in Review

Aventura Private Wealth held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 7 shares worth $126. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Aventura Private Wealth first reported a position in SRPT in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.2K in Q4 2024. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Aventura Private Wealth held 7 shares of Sarepta Therapeutics worth $126 as of Q2 2026.
  • Aventura Private Wealth left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #967 holding.
  • Aventura Private Wealth first reported a position in Sarepta Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Aventura Private Wealth's Sarepta Therapeutics position peaked at $12.2K in Q4 2024.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.